G G Neffinger|J W Schiff|S Abrams - JoVE Visualize

Showing results (271-280 of 623) with videos related to

Pageof 63

Sort By:

Nucleic Acids Research|December 24, 1998

Immobilization of acrylamide-modified oligonucleotides by co-polymerizationF N Rehman, M Audeh, E S Abrams, et al.

The Journal of Biological Chemistry|October 11, 1996

Phosphopleckstrin inhibits gbetagamma-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinaseC S Abrams, J Zhang, C P Downes, et al.

Science (New York, N.Y.)|May 9, 1986

Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesisG Zurawski, M Benedik, B J Kamb, et al.

Blood Advances|March 20, 2026

Novel use of a Hash-Based Tokenization for Sharing Sickle Cell Disease Data Without Sharing PHINajibah Galadanci, Gerhard Stefan Hellemann, Samuel David Washko, et al.

International Journal of Prisoner Health|March 17, 2017

Setting a minimum age for juvenile justice jurisdiction in CaliforniaElizabeth S Barnert, Laura S Abrams, Cheryl Maxson, et al.

Pediatric Surgery International|January 28, 2004

Diagnostic laparoscopy with planned appendectomy: an integral step in the evaluation of unexplained right lower quadrant painJames M DeCou, Michael W L Gauderer, John T Boyle, et al.

Contraception|February 15, 2003

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological propertiesGeoffrey L Hammond, Larry S Abrams, George W Creasy, et al.

Domestic Animal Endocrinology|September 10, 2003

Endotoxin inhibition of luteinizing hormone in sheepJ A Daniel, M S Abrams, L deSouza, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997

Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunityJ P McLaughlin, S Abrams, J Kantor, et al.

Journal of the National Cancer Institute|July 17, 1991

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinomaH L Parnes, J S Abrams, N Tait, et al.

Pageof 63

Showing results (271-280 of 623) with videos related to

Sort By:

Pageof 63

Nucleic Acids Research|December 24, 1998

Immobilization of acrylamide-modified oligonucleotides by co-polymerizationF N Rehman, M Audeh, E S Abrams, et al.

The Journal of Biological Chemistry|October 11, 1996

Phosphopleckstrin inhibits gbetagamma-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinaseC S Abrams, J Zhang, C P Downes, et al.

Science (New York, N.Y.)|May 9, 1986

Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesisG Zurawski, M Benedik, B J Kamb, et al.

Blood Advances|March 20, 2026

Novel use of a Hash-Based Tokenization for Sharing Sickle Cell Disease Data Without Sharing PHINajibah Galadanci, Gerhard Stefan Hellemann, Samuel David Washko, et al.

International Journal of Prisoner Health|March 17, 2017

Setting a minimum age for juvenile justice jurisdiction in CaliforniaElizabeth S Barnert, Laura S Abrams, Cheryl Maxson, et al.

Pediatric Surgery International|January 28, 2004

Diagnostic laparoscopy with planned appendectomy: an integral step in the evaluation of unexplained right lower quadrant painJames M DeCou, Michael W L Gauderer, John T Boyle, et al.

Contraception|February 15, 2003

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological propertiesGeoffrey L Hammond, Larry S Abrams, George W Creasy, et al.

Domestic Animal Endocrinology|September 10, 2003

Endotoxin inhibition of luteinizing hormone in sheepJ A Daniel, M S Abrams, L deSouza, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997

Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunityJ P McLaughlin, S Abrams, J Kantor, et al.

Journal of the National Cancer Institute|July 17, 1991

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinomaH L Parnes, J S Abrams, N Tait, et al.

Pageof 63